Table 3. Socio-demographic and clinical characteristics of MB patients from the U-MDT arm that relapsed during active follow up period.
| Case # |
Age at diagnosis (years) |
Gender | Date of U-MDT start (month/ year) |
Ridley Jopling Classification at diagnosis |
Relapse Date (month/ year) |
Ridley Jopling Classification at relapse |
Initial aBI | Lowest aBI/ date (month/ year) |
aBI at Relapse |
|---|---|---|---|---|---|---|---|---|---|
| CE 0126 |
32 | M | 06/2007 | BL | 09/2011 | LL | 4.0 | 1.25 06/2010 |
4.0 |
| CE 0188 |
20 | M | 09/2007 | LL | 11/2014 | LL | 3.5 | 3.0 07/2014 |
4.2 |
| CE 0208 |
17 | M | 10/2007 | LL | 04/2015 | LL | 4.75 | 1.0 09/2011 |
4.0 |
| AM 0014 |
33 | M | 04/2007 | LL | 04/2011 | LL | 4.5 | 0.25 07/2010 |
3.0 |
M: male aBI: average bacilloscopic index; BL:borderline lepromatous; LL: lepromatous.